Biotech
Precision Bio raising $37 million from investors
Posted by Jodi Leese Glusco | Mar 6, 2024
Durham-based Precision Biosciences is raising $37.1 million by selling shares in the company as well as warrants to investors, according to a filing with the Securities and Exchange Commission.
Read MoreURO-1 prepares for commercial launch of prostate biopsy platform
Posted by Jodi Leese Glusco | Feb 29, 2024
A Greensboro medical device company has patented a biopsy platform with a needle it says will offer physicians a more thorough, accurate and efficient tissue sampling and retrieval method.
Read MoreDurham-based Avicenna raises $6 million for ALS drug research
Posted by Jodi Leese Glusco | Feb 26, 2024
The company previously raised $2.5 million in September 2020 and $3 million in December 2022, according to Crunchbase.
Read MoreUS rivalry with China expands to biotech. Lawmakers see a failure to compete and want to act
Posted by Jodi Leese Glusco | Feb 19, 2024
U.S. lawmakers are raising alarms about what they see as America’s failure to compete with China in biotechnology, warning of the risks to U.S. national security and commercial interests.
Read MoreJLL names Research Triangle as nation’s top biomanufacturing hub
Posted by Jodi Leese Glusco | Feb 5, 2024
Though JLL has produced a life sciences industry report for years, this is the first one that has broken out the important biomanufacturing segment.
Read MoreTriangle ranks as 4th top biotech hub in US according to new report
Posted by WRAL TechWire | Jul 7, 2022
North Carolina’s Research Triangle region is the nation’s fourth leading hub for biotechnology activity, trailing only Boston, San Francisco and San Diego, says Fierce Biotech, an online publication that covers the biotechnology and pharmaceutical industries.
Read MoreAmgen to offer workers an average salary of $119,510 at new facility
Posted by WRAL News | Mar 7, 2022
At Amgen’s new facility in Holly Springs, the company plans to employ 355 people from 2025 through 2029 at an average salary of $119,510.
Read MoreRaleigh-based startup CEO lauded, lands on Forbes 30 under 30
Posted by WRAL News | Dec 13, 2021
Stephanie Michelsen, 27, is being recognized by Forbes. She made their prestigious 30 under 30 list. Michelsen is the CEO and founder of Jellatech, a biotechnology startup that synthesizes animal proteins in a cruelty-free way. “Our mission is to build a future that does not rely on animals and...
Read More- 1
- 2